Andesa Financial Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Andesa Financial Management's PFE Position: Q1 2023 in Review
Andesa Financial Management increased its Pfizer (PFE) stake by 73% in Q1 2023, buying an estimated $211K and bringing the position to 11,613 shares worth $218K. The position accounts for 0.11% of the portfolio, ranked #118.
Andesa Financial Management first reported a position in PFE in Q4 2017 and has held it in 19 quarters since. The position peaked at $4.9M in Q1 2019. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Andesa Financial Management held 11,613 shares of Pfizer worth $218K as of Q1 2023.
- Andesa Financial Management bought 4,887 Pfizer shares in Q1 2023, an estimated $211K.
- Pfizer made up 0.11% of Andesa Financial Management's portfolio in Q1 2023, its #118 holding.
- Andesa Financial Management first reported a position in Pfizer in Q4 2017 and has held it in 19 quarters since.
- Andesa Financial Management's Pfizer position peaked at $4.9M in Q1 2019.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.